The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

The FDA has approved Gammagard Liquid ERC as a replacement therapy for PI in adult and pediatric patients 2 years of age and older.

Toxoplasma gondii is a widespread parasite responsible for toxoplasmosis, an infection that often lacks clear symptoms but ...

Biogen BIIB initiated dosing in a global, late-stage study of its investigational candidate, felzartamab, for treating adult ...

The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...

The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous ...

Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults with primary membranous nephropathy (PMN)There are currently no therapies spec ...

A bispecific monoclonal antibody targeting psl and pcrV for chronic Pseudomonas aeruginosa infection in patients with bronchiectasis: Results from a randomized, double-blind, placebo-controlled ...

Elanco Animal Health Incorporated announced today that its Canine Parvovirus Monoclonal Antibody (CPMA) has become the first US Department of Agriculture conditionally approved treatment that targets ...

Anti-CD74 IgA antibodies were measured using the AESKULISA SpA Detect Kit (AESKU Diagnostics, Wendelsheim, Germany) as described in (1); values are expressed in U/mL. Analyses were restricted to ...

Epidemiological findings suggest a potential role for anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) pathogenesis. ACPA-positive RA is associated with unique genetical and ...

This new article explores some of the possible reasons behind gluten sensitivity, such as various allergens and infections.